Showing results (301-310 of 384) with videos related to

Sort By:
Pageof 39
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanolMaciej L Goniewicz, Christopher M Havel, Margaret Wilson Peng, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2017
Lung Microbiota Is Related to Smoking Status and to Development of Acute Respiratory Distress Syndrome in Critically Ill Trauma PatientsAriane R Panzer, Susan V Lynch, Chaz Langelier, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|January 8, 2019
Evaluating the temporal relationships between withdrawal symptoms and smoking relapseJason D Robinson, Liang Li, Minxing Chen, et al.
Preventive Medicine|April 1, 2018
Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public healthTracy T Smith, Dorothy K Hatsukami, Neal L Benowitz, et al.
JAMA|June 14, 2022
Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical TrialLisa Sanderson Cox, Nicole L Nollen, Matthew S Mayo, et al.
Critical Care Medicine|October 12, 2010
Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patientsS Jean Hsieh, Lorraine B Ware, Mark D Eisner, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 10, 2012
Effects of menthol on the pharmacokinetics of bupropion among Black smokersKolawole S Okuyemi, Babalola Faseru, Gregory A Reed, et al.
The Lancet. Respiratory Medicine|January 16, 2015
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trialCaryn Lerman, Robert A Schnoll, Larry W Hawk, et al.
Addictive Behaviors|December 21, 2012
Predictors of cessation in African American light smokers enrolled in a bupropion clinical trialBabalola Faseru, Nicole L Nollen, Matthew S Mayo, et al.
Drug and Alcohol Dependence|January 22, 2026
Sustained effects of reduced nicotine cigarettes and co-use of non-combusted alternative nicotine delivery systems: A one-month follow-up to a randomized clinical trialElias M Klemperer, Xianghua Luo, Qing Cao, et al.
Pageof 39